Video
Qlaris Bio announces positive data from 2 clinical trials investigating QLS-111 in patients with primary open angle glaucoma and ocular hypertension
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Regeneron reveals positive results from multiple trials evaluating Eylea HD (aflibercept) injection 8 mg
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
4DMT announces positive 52-week data from phase 2b cohort of PRISM wet AMD study
Study finds COVID-19 led to significant decline in common eye surgeries